Evidence map›Paper›PMID 39451039›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2024

Development of a Spectral Flow Cytometry Analysis Pipeline for High-dimensional Immune Cell Characterization.

Donald Vardaman, Md Akkas Ali, Md Hasanul Banna Siam, Chase Bolding, Harrison Tidwell, Holly R Stephens, Mallikarjun Patil, Daniel J Tyrrell

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Donald VardamanDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL.ORCID 0009-0004-7999-9458
Md Akkas AliDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL.ORCID 0000-0002-3626-3393
Md Hasanul Banna SiamDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL.ORCID 0000-0002-5883-2841
Chase BoldingDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL.
Harrison TidwellDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL.
Holly R StephensDepartment of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, AL.ORCID 0009-0004-7440-5438
Mallikarjun PatilDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL.ORCID 0000-0001-6406-1513
Daniel J TyrrellDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL.ORCID 0000-0002-0811-6724

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Omer Jamy · 1985 to 2026
$165.9M
Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Paul A. Goepfert · 1988 to 2026
$84.1M
Sex hormones and arthritis in a long lived animal modelP30AG050886 · NIA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Daniel L Smith · 2015 to 2026
$11.3M
Cerebrovascular Mitochondrial Function in Aging and Ischemic InjuryR00AG068309 · NIA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI TYRRELL, DANIEL · 2022 to 2024
$744k
Multi-parameter, analytic flow cytometerS10OD032296 · OD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI RANDALL, TROY D · 2022 to 2022
$464k
Development of RNAi as Treatment for NeurodegenerationR21AG024063 · NIA · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI KOSIK, KENNETH STEPHEN · 2004 to 2005
$288k
Immune Basis of how Inflammation, Atherosclerosis, and Aging Enhance Atrial FibrillationF32HL140728 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TYRRELL, DANIEL · 2018 to 2020
$165k
American Federation for Aging Research (AFAR) A24063NCI NIH HHS P30 CA013148NHLBI NIH HHS F32 HL140728NIAID NIH HHS P30 AI027767NIA NIH HHS P30 AG050886NIA NIH HHS R00 AG068309NIH HHS S10 OD032296
6 · The paper itself

Abstract

Flow cytometry is used for immune cell analysis for cell composition and function. Spectral flow cytometry allows for high-dimensional analysis of immune cells, overcoming limitations of conventional flow cytometry. However, analyzing data from large Ab panels is challenging using traditional biaxial gating strategies. We present, to our knowledge, a novel analysis pipeline to improve analysis of spectral flow cytometry. We employ this method to identify rare T cell populations in aging. We isolated splenocytes from young (2-3 mo old) and aged (18-19 mo old) female C57BL/6N mice and then stained these with a panel of 20 fluorescently labeled Abs. We performed spectral flow cytometry and then data processing and analysis using Python within a Jupyter Notebook environment to perform dimensionality reduction, batch correction, unsupervised clustering, and differential expression analysis. Our analysis of 3,776,804 T cells from 11 spleens revealed 35 distinct T cell clusters identified by surface marker expression. We observed significant differences between young and aged mice, with clusters enriched in one age group over the other. Naive, effector memory, and central memory CD8+ and CD4+ T cell subsets exhibited age-associated changes in abundance and marker expression. We also demonstrate the utility of our pipeline in a human PBMC dataset that used a 50-fluorescent color panel. By leveraging high-dimensional analysis methods, we provide insights into the immune aging process. This approach offers a robust and easily implemented analysis pipeline for spectral flow cytometry data that may facilitate the discovery of novel therapeutic targets for age-related immune dysfunction.

Indexed as

Flow CytometryMice, Inbred C57BLAgingAnimalsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesFemaleHumansImmunophenotypingMiceSpleenT-Lymphocyte Subsets

Identifiers

PMID39451039
PMCPMC11573633

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.